# Clinical Pharmacodynamic Bioequivalence Study of Beclomethasone Dipropionate 40 mcg INH

> **NCT04051710** · PHASE3 · COMPLETED · sponsor: **Aurobindo Pharma Ltd** · enrollment: 1550 (actual)

## Conditions studied

- Bronchial Asthma

## Interventions

- **DRUG:** Test Product
- **DRUG:** Reference Product
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04051710
- **Lead sponsor:** Aurobindo Pharma Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-12
- **Primary completion:** 2019-08-29
- **Final completion:** 2019-12-20
- **Target enrollment:** 1550 (ACTUAL)
- **Last updated:** 2020-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04051710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04051710, "Clinical Pharmacodynamic Bioequivalence Study of Beclomethasone Dipropionate 40 mcg INH". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04051710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*